Eurofins bioskin is delighted to celebrate 30 years of passion for dermatological trials.

Founded in 1992 by Dr Johannes Gassmueller and headquartered in Hamburg, Germany, bioskin is a full-service dermatology specific CRO. From a tiny but motivated team of 3 people in 1992, bioskin has grown to more than 60 experts in their fields, thus becoming one of the leading dermatology CROs that joined the Eurofins network of companies in 2021. bioskin supports Eurofins’ continued growth plans and strengthens its strong global clinical network allowing one-stop-shop for our customers and access to multicentric studies.

“We are enthusiastic to write another chapter in the success story of bioskin, continuously helping our clients to bring their dermatological drugs and medical devices to the market“, said bioskin CEO Walter Wigger-Alberti, MD.

Over the past 30 years, bioskin has earned a reputation for excellence in conducting dermatology clinical trials for drugs and medical devices.

Whilst we are very proud of what we have achieved, at this point we would like to thank our clients for 30 years of trust.